The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $65.05

Today's change+1.75 +2.77%
Updated September 30 3:39 PM EDT. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $65.05

Today's change+1.75 +2.77%
Updated September 30 3:39 PM EDT. Delayed by at least 15 minutes.

NU Skin Enterprises Inc Hits New 100-day High

NU Skin Enterprises Inc is up sharply today, rallying (U.S.)$1.75 or 2.77% to (U.S.)$65.05 and setting a new 100-day high. Over the last five days, shares have gained 3.06% and 71.69% year to date. Shares have outperformed the S&P 500 by 44.42% during the last year.

Key company metrics

  • Open(U.S.) $63.33
  • Previous close(U.S.) $63.30
  • High(U.S.) $65.10
  • Low(U.S.) $63.31
  • Bid / Ask(U.S.) $65.04 / (U.S.) $65.06
  • YTD % change+71.69%
  • Volume567,950
  • Average volume (10-day)810,479
  • Average volume (1-month)651,417
  • Average volume (3-month)688,445
  • 52-week range(U.S.) $23.51 to (U.S.) $65.10
  • Beta1.85
  • Trailing P/E37.12×
  • P/E 1 year forward21.86×
  • Forward PEG2.70×
  • Indicated annual dividend(U.S.) $1.42
  • Dividend yield2.18%
  • Trailing EPS(U.S.) $1.75
Updated September 30 3:39 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.52%

Based on its net profit margin of 4.52%, NU Skin Enterprises Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue600472572571
Total other revenue--------
Total revenue600472572571
Gross profit472334451419
Total cost of revenue128138121153
Total operating expense521464510529
Selling / general / administrative392326389376
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income8086243
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax6955828
Income after tax4533616
Income tax, total2422312
Net income4533616
Total adjustments to net income--------
Net income before extra. items4533616
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4533616
Inc. avail. to common incl. extra. items4533616
Diluted net income4533616
Dilution adjustment--------
Diluted weighted average shares56565859
Diluted EPS excluding extraordinary itemsvalue per share0.790.060.620.28
Dividends per sharevalue per share0.360.360.350.35
Diluted normalized EPSvalue per share0.790.060.620.28